Halia Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Halia Therapeutics at ASH 2026 in New Orleans: Booth 457.
| Organization | ASH 2026 Attendance |
|---|---|
Halia Therapeutics Lehi, UT | |
Clinical-stage company targeting the LRRK2, NEK7 and NLRP3 inflammation pathway; its NEK7 modulator HT-6184 is in Phase 2 for MDS. | Booth Exhibiting at Booth 457 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Halia Therapeutics
Tell us what you sell and we’ll find the people at Halia Therapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction